Motif Bio Share Discussion Threads

[scottdavid70] 22/12/2020 21:00

It’s also why I believe that unless Lumsden address clearly and concisely what’s gone on here from the time time
Of the CRL he should never sit on a BoD again and as the worst CEO in history in my humble opinion never do that job again.

He still wants a BONUS even after all of that and what he has put investors through. Zero shame

[scottdavid70] 22/12/2020 20:43

I goess the thing that is most central to my book is the theme of saying one thing and then it not happening such as:

NDA submission late - one shot at goal? Or was it then that the liver issue was known that made them have liver experts on standby for the FDA?

EMA submission in - quirky pulled with no RNS just slipped in a investor presentation

Same with the HABP trials

Then the no clinical trials

Then the all bases covered

Then the moving of the AGM to before the FDA decision

Then the Iclaprim tie up with Lamellar and news in a few months - still nothing

Full phase 3 trials and several years - huge funding and so reclassified as a shell company- vote needed otherwise company goes under - sound like all bases covered when on that type of knife edge?

US Army trials announced to much fanfare - still nothing

Strategic business partner for several Covid therapeutic companies- still no deal

Fully funded till Feb 2021 - interims state significant dilution possible again for investors- why?

Samdoz new patents for Iclaprim- we aren’t told anything

Strict cost controls 2019 - almost US $1.1 million for two directors in 2019

Nasdaq needed for company to grow - sucked in too much cash for extra regulations - delist - vanity project for Graham most of us now think

No Board reviews last year after a catastrophic year - why? Not good Corporate Governance

Opaque RNS - several term sheets agreed yet still searching for a suitable a RTO. What exactly does that mean? The ones at Term Sheets aren’t good enough?

Investors deserve better by their Directors than this mini resume of what’s gone on here

[scottdavid70] 22/12/2020 19:52

Scammed...

[scottdavid70] 22/12/2020 18:55

On top of that we need a prospectus, a vote and a RTO done by the 28th January.

Zero change that happens

Gold just going to take his last $25,000 in January and run away as they all have ultimately

[scottdavid70] 22/12/2020 18:54

Laughable how they feel we have fallen for their ruse about 40 companies and several at term sheet stage but the “search goes on for a suitable RTO” ok if the term sheets were needing to be negotiated it would shave been done a month ago so clearly they had fallen away otherwise why say the search goes on. Just trying to ale themselves look adequate at best but failing miserably

[scottdavid70] 22/12/2020 14:06

To be fair the no clinical trails comment on the WebCast of the 19th February 2019 that ended up being another full phase 3 trail costing $40
Million and 3.5 years is how did that part it...disingenuous at best:-)

[scottdavid70] 22/12/2020 13:40

The main thrust of the story for them is the strict cost controls supposedly Motif was under in 2019 and the almost US $1.1 MILLION two Director’s took home along with a few pensionable benefits and are THEN IN LINE FOR A BONUS AND A HUGE AMOUNT IN DEFERRED PAYMENTS. This draining affect in terms of dilution through unnecessary fund raises has brought the Board of Directors culpable for these vast sums to be paid out sharply into focus along with the affiliated companies involved such as Walbrook and Peel Hunt. Reputation damage here is simply immense.

That is simply unpalatable to them in these horrendous times for ordinary investors caught up in the Machiavellian spin that has unfolded here

[scottdavid70] 22/12/2020 13:20

Holding people accountable is extremely en bouvier at these difficult times. Certainly this story is resonating with a lot of different media outlets

[scottdavid70] 22/12/2020 12:22

Walbrook
Northland Capital
Peel Hunt X 100
Zacks
Motif Bio all Board Members past and current
SP Angel

[scottdavid70] 22/12/2020 12:21

Utterly disgusting and shambolic way to treat shareholders who have funded their lavish lifestyles. Going stealth isn’t going to make people forget what has unfolded here.

Regardless what unfold here ultimately there has to be a review, something I appreciate they don’t like to do judging by their 2019 lack of as per Corporate Governance, by others to see if these Directors are fit to continue as such in the future.

[jimbob999] 22/12/2020 11:27

Wake up wake up MTFB board of directors

[scottdavid70] 22/12/2020 09:24

So a new variant of Covid - vaccine may not work - therefore therapeutics very important

AMR Fund needing new antibiotics to get 3-4 new antibiotics to market in 10 years - we have one that needs 3.5 years and a mere $40 million - they have a billion dollars to spend

Supposedly 30 companies wanted to do a RTO and several have got to Term Sheet stage

So the question is why hasn’t a deal been done as we have less than 30 business days till the company delists

All bases covered still Graham?

[scottdavid70] 21/12/2020 20:31

I see Walbrook are pumping Great Western Mining via their usual media outlet Proactive. Gold and silver coming in December if you believe it...

Wait till the Motif story gets told soon. No one will touch anything promoted via those channels

Gold is promised here too $325,000 in deferred payments...

[scottdavid70] 21/12/2020 17:55

Several competitors at Term Sheet stage is enough to keep them competitive to do the best deal. No need to keep searching for a MORE suitable one when you have had a choice of 30 FFS. Amongst them there was definitely one better than we currently had.

Sadly the wrong people are at the helm and that’s because there was no Board review in 2019 against everything Corporate Governance stands for

[scottdavid70] 21/12/2020 17:52

I agree Chuffer - looking back now at the 12th October Interims where it says several companies have reached the term sheet stage BUT the SEARCH is still on for a suitable RTO they were trying to obfuscate the fact those term sheets were no longer in play.

Rinse and repeat methodologically from these quite special breed of Directors sadly

More for the book

[chuffer2] 21/12/2020 15:18

Not that is was ever on!

[scottdavid70] 21/12/2020 15:05

Term Sheet to deal - 4-5 weeks in general

Would appear it’s all off as we haven’t heard from the company

No other reason for the complete silence as far as my experience tells me

[chuffer2] 21/12/2020 14:36

No point as they are just another leech sucking money from the pot.
Have yet to see a pr/ir company that looks after shareholders they simply get paid a lot of money as a front for corrupt bod members.

[scottdavid70] 21/12/2020 14:34

I will say it again 2018 was the year of ‘strict cost controls’ and two directors here trousered almost US $1.1 million in salary.

1) That doesn’t sound like strict cost control to anyone I speak too

2) with that money neither bought shares in the company. Would have showed a bit of confidence and solidarity with shareholders but no that would have been wasting cash like they have asked shareholders to do given the predictions they have made to pay them so handsomely

3) They still want a Bonus - Lumsden a straight up one and Gold a deferred one. $100,000 and $325,000 respectively if they close a RTO

[scottdavid70] 21/12/2020 14:29

Several interested parties in June - Peel Hunt whom have surveyed the skeletons here for a millionth time needed to advise a Board that hadn’t done a review of its make up or performance in 2019 as per Corporate Governance - thereby eating up valuable cash that they could have saved if they had done Corporate Governance and got people on the Board whom understand RTO’s - Term Sheets 12th October written in such a way as to read it both ways possible still active or not given they are still searching for a suitable RTO in the next sentence- 70 days later the sound of crickets from all involved here. What could have gone wrong given everything has gone so right before now....

[scottdavid70] 21/12/2020 14:24

Chuffer - you called up Walbrook recently and asked them? You seem to have a better relationship with them than me for some unknown reason...

[scottdavid70] 21/12/2020 10:39

So why is there a possibility in the Interims of shareholders being significantly diluted again given we were told that the company was fully funded?

When’s enough Graham and Jon?

[scottdavid70] 21/12/2020 10:38

They were fully funded supposedly in May 2018 and raised $10 million for regulatory and pre-authorisation supposedly. What they ended up doing was dropping the EMA submission and HABP trials. So what happens to the money earmarked for those two significant events? We know the millions raised have been trousered by two of the Directors under ‘strict cost controls’

[scottdavid70] 21/12/2020 10:36

One thing this company is very good at is giving no updates -

No update on the Lamellar tie from May last year

No update on US Army trials from October last year

No update on Iclaprim situation

No update on Term Sheet negotiations

What they are good at is slipping in things like no Board Reviews which goes against good Corporate Governance and significant dilution potential in Annual and Interim Reports even when they have stated they are fully funded

[scottdavid70] 21/12/2020 07:55

So the deals that were on offer to get Peel Hunt involved looked good enough for Motif to pay them yet here we are 7
Months later with no deal?

Money for old rope